We describe Caucasian monozygotic twin brothers with rheumatoid arthritis (RA) and discuss influence of predictors to methotrexate (MTX) outcome treatment. Co-medication biologics and MTX may impact on radiographic progression despite predicted bad MTX outcome in pharmacogenetic analysis.